GATC Health is accelerating the world's transition to individualized medicine. Our Multiomic Advanced Technology™ (MAT) platform analyzes comprehensive biological datasets including genomics (multiomics) to provide insight into individualized, specific health risks. From these insights GATC Health precisely identifies specific methods to greatly reduce or mitigate health risks before they manifest. We call this Predictive Multiomics™.